| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
| Adjustments for Liabilities & Assets: | 329379.00 | -110563.30 | -655007.70 | -180077.80 | 368353.30 |
| Cash Flow from operating activities | 606685.80 | 150465.00 | -399778.70 | 9189.90 | 591176.60 |
| Cash Flow from investing activities | -24612.40 | -17480.00 | -12378.00 | -12558.80 | -10291.40 |
| Cash Flow from financing activities | -35059.90 | -38344.70 | 4453.60 | 40354.50 | 2900.80 |
| Effect of exchange fluctuation on translation reserve | 240.70 | -21.60 | 817.00 | -1735.10 | -873.30 |
| Net increase/(decrease) in cash and cash equivalents | 547013.50 | 94640.30 | -407703.10 | 36985.60 | 583786.00 |
| Opening Cash & Cash Equivalents | 1511646.90 | 1417028.20 | 1823914.30 | 1788663.80 | 1205751.00 |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalent of Subsidiaries under liquidations | 0 | 0 | 0 | 0 | 0 |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | 0 | 0 | 0 | 0 | 0 |
| Effect of Foreign Exchange Fluctuations | 0 | 0 | 0 | 0 | 0 |
| Closing Cash & Cash Equivalent | 2058901.10 | 1511646.90 | 1417028.20 | 1823914.30 | 1788663.70 |
